Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03647267 · ClinicalTrials.gov registry record · Phase 3

Effects of Pneumatic Vitreolysis on Vitreomacular Traction

A Phase 3 study, sponsored by Jaeb Center for Health Research.

Completed
Registry status
Phase 3
Development phase
46
Enrollment target

NCT03647267: Completed Phase 3 study, sponsored by Jaeb Center for Health Research.

NCT03647267 is a Phase 3 study that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 46 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03647267, a Phase 3 study, has completed, sponsored by Jaeb Center for Health Research.

COMPLETED
Registry status
Phase 3
Development phase
46 participants
Enrollment target

Study Summary

Eyes with idiopathic symptomatic vitreomacular traction (VMT) without a macular hole will be randomly assigned to 0.3-mL intraocular gas (C3F8) injection or sham injection to determine if pneumatic vitreolysis (PVL) is effective in releasing VMT.

Interventions

  • OTHER Observation
  • DEVICE Pneumatic Vitreolysis (C3F8 injection)

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2018-10-16
Est. Completion 2020-08-06
Phase Phase 3
Jaeb Center for Health Research

119 total trials

What the finished NCT03647267 record still lists

NCT03647267 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 2 interventions - of which Observation is the first listed.

NCT03647267 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03647267 about?

NCT03647267 is a clinical study titled "Effects of Pneumatic Vitreolysis on Vitreomacular Traction". Eyes with idiopathic symptomatic vitreomacular traction (VMT) without a macular hole will be randomly assigned to 0.3-mL intraocular gas (C3F8) injection or sham injection to determine if pneumatic vitreolysis (PVL) is effective in releasing VMT.

What is the current status of trial NCT03647267?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 46 participants. The study started on 2018-10-16. Estimated completion is 2020-08-06.

What interventions are being tested in trial NCT03647267?

The interventions under investigation include: Observation (OTHER), Pneumatic Vitreolysis (C3F8 injection) (DEVICE).

Who is sponsoring clinical trial NCT03647267?

This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03647267's enrollment target sits among peer trials

46 1868th of 2000 higher than 131 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03647267, the US trial registry maintained by the National Library of Medicine. NCT03647267 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.